Springer

Drugs - Real World Outcomes

(ISSN 2198-9788)

Drugs - Real World Outcomes targets original research and definitive reviews regarding the use of real-world data to evaluate health outcomes and inform healthcare decision-making on drugs, devices and other interventions in clinical practice. The journal includes, but is not limited to, the following research areas:

Using registries/databases/health records and other non-selected observational datasets to investigate:

drug use and treatment outcomes

prescription patterns

drug safety signals

adherence to treatment guidelines

benefit : risk profiles

comparative effectiveness

economic analyses including cost-of-illness

Data-driven research methodologies, including the capture, curation, search, sharing, analysis and interpretation of ‘big data’

Techniques and approaches to optimise real-world modelling.

Additional digital features (including animated abstracts, video abstracts, slide decks, audio slides, instructional videos, infographics, podcasts and animations) can be published with articles; these are designed to increase the visibility, readership and educational value of the journal’s content. In addition, articles published in Drugs - Real World Outcomes may be accompanied by plain language summaries to assist readers who have some knowledge of, but not in-depth expertise in, the area to understand important medical advances.